Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-31

Clinical Trial Update: Safety and Efficacy Study of PUMCH-E101 Injection in Subjects with RDH12 Retinopathy [EARLY_Phase 1]

View source ↗

Summary

This record reports an early-phase 1 safety and efficacy trial of PUMCH-E101 Injection for RDH12 retinopathy, an inherited retinal disease, which is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PUMCH-E101 Injection

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Inherited Retinal Diseases | EARLY_Phase 1 | Status: RECRUITING